PATENT CLAIM ANALYSIS

Application Number: 15903414
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-06
Patent Classification: ["548", "125000"]

Abstract:
The present invention is directed to 1,2,5-oxadiazole derivatives, and compositions of the same, which are inhibitors of indoleamine 2,3-dioxygenase and are useful in the treatment of cancer and other disorders, and to the processes and intermediates for making such 1,2,5-oxadiazole derivatives.

Claim (Index 177):
A compound, which is 4-({2-[(aminosulfonyl)amino]ethyl}amino)-N-(3-bromo-4-fluorophenyl)-N\u2032-hydroxy-1,2,5-oxadiazole-3-carboximidamide, wherein one or more hydrogen atoms are replaced by deuterium.

Metadata:
- Claim Count in Document: 3.0
- Percentile: 88.0
- Lexical Diversity: 1.45161
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['12498782', '14033117', '14661191', '15093420', '14322362']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.735449028218754
- 35 USC 102 Novelty (BERT): 0.5287983650525234
- Combined Prediction Score: 0.7147839619021309
- Mean Citation Score: 337.17536
- Max Citation Score: 338.56656
- Similarity Product: 269.3693458351135

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test